Study reveals personality disorders and schizophrenia are the most debilitating mental illnesses to live with.
The SARM1 protein triggers a cascade of degeneration associated with Alzheimer's, Parkinson's, and other neurodegenerative diseases. Researchers hope new drugs can be developed to directly target this protein to fight neurodegeneration.
Researchers have identified a genetic link between depression and an increased risk of developing stomach ulcers.
Study identifies a new "seeding" process in neurons that could be a cause of dementia and Alzheimer's disease.
Vitamin D deficiency during pregnancy may explain why males are three times more likely to be diagnosed with ASD than girls. The study reports prenatal vitamin d deficiency increases testosterone in the developing male brain.
Mutations in the inflammatory RIPK1 gene have been identified in people with obesity. The variation caused an increased amount of the gene in fat tissue. This increased risk of obesity.
Study found genes implicated in cattle temperament contribute to neural developmental functions and are differentially expressed in the human brain. Some ASD related genes are associated with cattle temperament.
Discovery reveals neurons can lose their individuality in some conditions. The findings contradict the conventional belief that neurons always stay separated and never fuse.
Researchers identified a specific neural network that positively responds to melatonin following concussion in children. Results suggest melatonin may help compensate for normal brain function that has been interrupted due to injury caused by concussion and helps prevent sleep disturbances.
The ability to extinguish fear memories may rely on the flexibility of a person's DNA.
Children who experience emotional, mental health, and social problems are more likely to have higher levels of genetic vulnerability for depression as adults. Researchers also identified a higher genetic vulnerability for insomnia, body mass index, and neuroticism. 50% of children with disorders such as ADHD continue to experience mental health problems as they enter adulthood.
Six potential drug candidates have been identified as candidates to treat COVID-19 infections. The drugs, which have previously been subjected to clinical trials for treating a range of conditions, from arthritis to cancer, target Mpro, the main SARS-CoV-2 enzyme.
